Schmitz H, Kampa D, Heidenreich W
Int J Cancer. 1975 Dec 15;16(6):1030-4. doi: 10.1002/ijc.2910160617.
The anti-complement immunofluorescence (ACIF) test was modified to detect non-complement-fixing antibodies to Epstein-Barr (EB) virus nuclear antigen (IBNA). These EBNA antibodies belong to the immunoglobulin classes IgA and IgG. In our method anti-human gamma-globulin (AHG) was bound to the EBNA antibodies before the complement was added. If only non-complement-fixing antibodies are present the complement can be fixed to the AHG. Within only a few weeks of the onset of infectious mononucleosis (IM) the non-complement-fixing EBNA antibodies reach high titers while the complement-fixing antibodies (detected by the ACIF test) are not yet present. Anti-EBNA-IgM antibodies were not found in the IgM fractions of sera taken at different stages of IM.
抗补体免疫荧光(ACIF)试验经过改良,用于检测针对爱泼斯坦 - 巴尔(EB)病毒核抗原(EBNA)的非补体结合抗体。这些EBNA抗体属于免疫球蛋白IgA和IgG类。在我们的方法中,在加入补体之前,将抗人γ-球蛋白(AHG)与EBNA抗体结合。如果仅存在非补体结合抗体,则补体可固定于AHG。在传染性单核细胞增多症(IM)发病仅几周内,非补体结合的EBNA抗体达到高滴度,而补体结合抗体(通过ACIF试验检测)尚未出现。在IM不同阶段采集的血清IgM组分中未发现抗EBNA - IgM抗体。